In addition to its healing effect, the effect ofKAP is also based on the fact that it reliably inactivates bacteria and fungi:<\/p>\n
Terabe, Y., Kaneko, N. & Ando, H. Treating hard-to-heal skin and nail onychomycosis of diabetic foot with plasma therapy. Dermatol. Ther. 34, e15127 (2021).<\/p>\n
Gnat, S. et al. Cold atmospheric pressure plasma (CAPP) as a new alternative treatment method for onychomycosis caused by Trichophyton verrucosum: in vitro studies. Infection 49, 1233-1240 (2021).<\/p>\n
Borges, A. C. et al. Cold Atmospheric Pressure Plasma Jet Reduces Trichophyton rubrum Adherence and Infection Capacity. Mycopathologia 184, 585-595 (2019).<\/p>\n
Boxhammer, V. et al. Investigation of the mutagenic potential of cold atmospheric plasma at bactericidal dosages. Mutat. Res. 753, 23-28 (2013).<\/p>\n
Heinlin, J. et al. Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment. Future Microbiol. 8, 1097-1106 (2013).<\/p>\n
Kl\u00e4mpfl, T. G. et al. Decontamination of Nosocomial Bacteria Including Clostridium difficile Spores on Dry Inanimate Surface by Cold Atmospheric Plasma. Plasma Process. Polym. 11, 974-984 (2014).<\/p>\n
Daeschlein, G. et al. Skin and wound decontamination of multidrug-resistant bacteria by cold atmospheric plasma coagulation. J. Dtsch. Dermatol. Ges. J. Ger. Soc. Dermatol. JDDG 13, 143-150 (2015).<\/p>\n
Zimmermann, J. L. et al. Test for bacterial resistance build-up against plasma treatment. New J. Phys. 14, 073037 (2012).<\/div>